eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Janssen Research & Development - Comment

Janssen Research & Development - Comment

Document ID: FDA-2013-N-0059-0010
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: March 08 2013, at 12:00 AM Eastern Standard Time
Date Posted: March 20 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: February 6 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: March 8 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-8434-v23f
View Document:  View as format xml

View Comment

Please find attached Janssen comments.

Attachments:

Janssen Research Development Comment

Title:
Janssen Research Development Comment

View Attachment: View as format pdf

Related Comments

    View All
Total: 15
Janssen Research & Development - Comment
Public Submission    Posted: 03/20/2013     ID: FDA-2013-N-0059-0010

Mar 08,2013 11:59 PM ET
Lupus Foundation of Mid and Northern New York - Comment
Public Submission    Posted: 03/20/2013     ID: FDA-2013-N-0059-0008

Mar 08,2013 11:59 PM ET
Baxter Healthcare Corporation - Comment
Public Submission    Posted: 03/20/2013     ID: FDA-2013-N-0059-0007

Mar 08,2013 11:59 PM ET
Teva Pharmaceuticals - Comment
Public Submission    Posted: 03/20/2013     ID: FDA-2013-N-0059-0009

Mar 08,2013 11:59 PM ET
Association for Molecular Pathology (AMP) - Comment
Public Submission    Posted: 03/20/2013     ID: FDA-2013-N-0059-0003

Mar 08,2013 11:59 PM ET